HardyTAReddelSWBarnettMH, et al. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol2016; 15(9): 967–981.
2.
SeewannAEnzingerCFilippiM, et al. MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: A review of reported findings. J Neurol2008; 255(1): 1–10.
3.
AlmalkiDMMudhafarOYAlsamanAS, et al. Diagnostic uncertainty of tumefactive cystic demyelinating lesions. Neurosciences (Riyadh)2013; 18(2): 176–177.
4.
SilsbyMSánchezPSpiesJM, et al. Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosis. Mult Scler Relat Disord2019; 35: 104–107.
5.
CluseF, et al. Pseudocystic inflammatory demyelinating lesions in multiple sclerosis: A clinical, radiological, and pathological description. 2023; 29(10): 1342–1346
